EEF2K and Alzheimer disease: However, the excessive elongation brake attenuates neuronal responses to oxidative stress (Jan et al., 2017; Jan et al., 2018), so genetic or pharmacological inhibition of eEF2K can rescue neuronal loss and behavioral defects in mouse models of AD, PD and Dravet syndrome (Beretta et al., 2022).